Use of PSMA PET/CT imaging before salvage radiotherapy was linked to improved survival for patients with BCR prostate cancer ...
ALMOST half of Brits are unaware of a cancer type that is the leading cause of death in women under 60 years old. Though it ...
Justin Beal, a 39-year-old investigator with the University of Alabama Police Department, faces cancer surgery.
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
Felicia Willette, 34, of Brick has a genetic abnormality that has left her riddled with cancer at a time that her son is ...
Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and ...
Veteran actor and politician Nafisa Ali Sodhi, who first fought cancer in 2018, has once again found herself facing the ...
News-Medical.Net on MSN
Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
The Nation UAE on MSN
Pakistan Atomic Energy Commission’s Cancer Hospital Organizes World Radiotherapy Awareness Day
The Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), a leading cancer hospital of the Pakistan Atomic Energy ...
MedPage Today on MSN
Practice-Influencing Results in Oligometastatic Prostate Cancer
Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results